SCA
NVS icon

Salient Capital Advisors’s Novartis NVS Stock Holding History

Salient Capital Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,690
Closed -$650K – 147
2017
Q2 		$650K Sell
8,690
-2,578
-23% -$183K 0.01% 138
2017
Q1 		$750K Sell
11,268
-597
-5% -$39.8K 0.01% 150
2016
Q4 		$774K Sell
11,865
-56
-0.5% -$3.63K 0.01% 140
2016
Q3 		$843K Buy
11,921
+318
+3% +$23.2K 0.02% 124
2016
Q2 		$858K Sell
11,603
-2,597
-18% -$179K 0.02% 131
2016
Q1 		$922K Sell
14,200
-676
-5% -$46K 0.03% 128
2015
Q4 		$1.15M Sell
14,876
-10,736
-42% -$853K 0.03% 115
2015
Q3 		$2.11M Sell
25,612
-4,547
-15% -$405K 0.05% 96
2015
Q2 		$2.66M Buy
30,159
+1,690
+6% +$155K 0.05% 101
2015
Q1 		$2.52M Sell
28,469
-219
-0.8% -$19.4K 0.05% 97
2014
Q4 		$2.38M Buy
28,688
+1,887
+7% +$156K 0.05% 99
2014
Q3 		$2.26M Buy
26,801
+4,169
+18% +$337K 0.04% 111
2014
Q2 		$1.84M Buy
22,632
+3,060
+16% +$241K 0.04% 110
2014
Q1 		$1.49M Buy
19,572
+12,249
+167% +$893K 0.04% 114
2013
Q4 		$528K Buy
7,323
+2,132
+41% +$148K 0.02% 153
2013
Q3 		$357K Sell
5,191
-506
-9% -$33.5K 0.01% 137
2013
Q2 		$361K Buy
+5,697
New +$371K 0.02% 135

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Salient Capital Advisors's NVS Position: Q3 2017 in Review

Salient Capital Advisors sold out of Novartis (NVS) in Q3 2017, closing a stake of 8,690 shares — an estimated $650K sold.

Salient Capital Advisors first reported a position in NVS in Q2 2013 and held it in 17 quarters. The position peaked at $2.66M in Q2 2015. 938 funds tracked by Wall St. Rank hold NVS as of Q3 2017.

  • Salient Capital Advisors reported no remaining Novartis position as of Q3 2017 after selling out during the quarter.
  • Salient Capital Advisors sold 8,690 Novartis shares in Q3 2017, an estimated $650K.
  • Salient Capital Advisors first reported a position in Novartis in Q2 2013 and held it in 17 quarters.
  • Salient Capital Advisors's Novartis position peaked at $2.66M in Q2 2015.
  • 938 funds tracked by Wall St. Rank held Novartis as of Q3 2017.

Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.